Literature DB >> 24261056

Urinary tract calculi in military aviators.

William D Porter1, G Merrill Rice.   

Abstract

BACKGROUND: Urinary tract calculi are a common affliction in the United States and estimates of the adult lifetime risk of developing this condition range from 10 to 15%. Although highly variable, the clinical presentation of someone afflicted with urinary tract calculi typically involves varying degrees of pain, nausea, hematuria, and dysuria. Current disease, as well as a history of urinary tract calculi, is potentially disqualifying for aviation duties in the United States military as well as for commercial aviators.
METHODS: Utilizing population based data from the Defense Medical Epidemiology Database (DMED), the current descriptive epidemiology of urinary tract calculi among military aviators was examined.
RESULTS: Based on the data collected, the overall annual incidence density of urinary tract calculi for DoD personnel is approximately 4.8 events/1000 PY. The overall annual incidence density of urinary tract calculi is slightly lower in aviators as compared to the nonaviator DoD population (4.4 events/1000 PY vs. 4.8 events/1000 PY). DISCUSSION: Even though in-flight incapacitation from this malady is believed to be exceedingly rare, the incidence of urinary tract stones and their related morbidity should remain an important area of clinical focus.

Entities:  

Mesh:

Year:  2013        PMID: 24261056     DOI: 10.3357/asem.3597.2013

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  2 in total

1.  The prevalence of medical symptoms in military aircrew.

Authors:  Barak Gordon; Yifat Erlich; Erez Carmon
Journal:  Disaster Mil Med       Date:  2017-02-02

2.  Numerical characterization of astronaut CaOx renal stone incidence rates to quantify in-flight and post-flight relative risk.

Authors:  Debra A Goodenow-Messman; Suleyman A Gokoglu; Mohammad Kassemi; Jerry G Myers
Journal:  NPJ Microgravity       Date:  2022-01-28       Impact factor: 4.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.